- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02609763
Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale
November 29, 2015 updated by: Topokine Therapeutics, Inc.
This observational study will test the inter-rater and test-retest reliability of the LESS scale in a live context.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Eligible adults with varying degrees of lower eyelid steatoblepharon
Description
Inclusion Criteria:
- Must provide informed consent
Exclusion Criteria:
- Unable or unwilling to complete study procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
LESS score (Clinician-Reported)
Time Frame: Eyelids will be assessed on one day only (cross-sectional study)
|
Eyelids will be assessed on one day only (cross-sectional study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
November 16, 2015
First Submitted That Met QC Criteria
November 17, 2015
First Posted (Estimate)
November 20, 2015
Study Record Updates
Last Update Posted (Estimate)
December 2, 2015
Last Update Submitted That Met QC Criteria
November 29, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- TPK-SCALE-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Steatoblepharon
-
Topokine Therapeutics, Inc.Completed
-
Peregrine OphthalmicCompletedLower Eyelid SteatoblepharonUnited States
-
Topokine Therapeutics, Inc.CompletedLower Eyelid Steatoblepharon (Excess Eyelid Fat)United States